Sold before it exists: the company is already taking committed orders or reservations for output it cannot yet produce
The model's full reasoning — Q1 2018 call → NOWe need to determine if the transcript describes a situation where counterparties have already committed to take output, product, capacity, or service that the company is not yet able to deliver. That is, commitments are real and made, and the ability to supply does not yet fully exist, with the gap being closed now. Let's scan the transcript for any such situation. The call discusses various products: NovaSeq, iSeq, NextSeq, microarrays, etc. There are mentions of partnerships, collaborations, and orders. Key points: - iSeq: "we launched our iSeq platform in the first quarter and shipped units to customers for beta testing. During the beta test, we identified some opportunities to improve our corporate billing and shipping processes that will enhance product robustness and reliability. We are in the process of validating these improvements and expect to scale shipments midyear. In the meantime, we continue to see strong interest in iSeq and are approaching 100 orders." This indicates that iSeq is not yet fully scaled, but there are orders (approaching 100). However, are these orders commitments? They are orders, but the product is in beta, and they are scaling shipments midyear. The company is still validating improvements. So there is a product not yet fully delivered, but orders exist. However, is this a significant portion of future output? It's a small number (100 orders) and it's a new product. The question asks if counterparties have committed to take output that the company is not yet able to deliver. Here, they have orders, but the company is working to scale. But is this a "meaningful part" of future output? Probably not, given the scale of the company. Also, the company is not saying they can't deliver; they are scaling. The essence is that demand has been pulled forward past readiness. But here, it's a new product launch with beta testing, and they are scaling. It's not a situation where they have sold a large portion of future capacity. - NovaSeq: They talk about shipments, orders, and the upgrade cycle. But they are delivering NovaSeq already. No indication of commitments beyond what they can deliver. - Microarray: Strong growth, but they are delivering. - Partnerships: Loxo Oncology and BMS collaborations. These are for companion diagnostics. They mention milestones and revenue from these collaborations.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
GOGO · Q1 2016 → YESThe question is: Does management describe that counterparties have already committed to take output, product, capacity, or service that the company is not yet able to deliver? YES Management describes real commitments (Delta >600, IAG 130+, Shareco 50, Air Canada wide-body fleet, total 2Ku awarded >1000) already made by counterparties. They also state the company is not yet able to deliver at scale ("begin the enviable task of installing the 1000 2Ku awarded aircraft", "we expect to install the majority of our awarded aircraft by the end of 2018", "STCs... will keep us on track to exceed our 75 2Ku installation target this year", "supply chain is there", "aggressive STC program...
SYM · Q3 2022 → YESThe question is: Does management describe that counterparties have already committed to take output that the company is not yet able to deliver? Like a backlog of things they haven't built yet. YES The transcript shows management describing a $11.3 billion contracted revenue backlog (more than doubled) with customers having "voted with their wallets," alongside 13 systems currently in deployment (plus 6 fully ramped) that will take roughly 18 months to acceptance.
BXP · Q1 2022 → YESThe question is about whether management describes counterparties that have already committed to take output that the company is not yet able to deliver, like pre-leased developments that aren't built...YES The transcript shows multiple instances where management describes counterparties having already signed leases for space in developments that have not yet been completed or even commenced construction.